Skip to main content
BETA A NHS service powered by standards. Feedbackopens in a new window will help us improve.

Electronic Yellow Card Reporting

Defines a method for data submission about suspected adverse drug reactions via the Yellow Card Scheme by populating the majority of the Yellow Card submission from the patient's electronic record.

Documentation

About this standard

Publisher
NHS England
Reference code
DCB1582 Amd 16/2017
Publication date
26/10/2017
Publication version
3.0.0
Status
Active
Show definitions of statuses

Active. Active standards are stable, maintained and have been approved, assured or endorsed for use by qualified bodies.

Deprecated Deprecated standards are available for use and are maintained, but are being phased out, so new functionality will not be added.

Retired standards Retired standards are not being maintained or supported and should not be used.

Standard type
Information standards
Show definitions of standard types

Collections. A Collection is a systematic gathering of a specified selection of data or information for a particular stated purpose from existing records held within health and care systems and electronic devices.

Extractions. An extraction is a type of collection that is pulled from an operational system by the data controller and transmitted to the receiver without additional processing or transcription by the sender.

Information standards. Information standards are agreed ways of doing something, written down as a set of precise criteria so they can be used as rules, guidelines, or definitions.

Technical Standards and specifications. Technical standards and specifications specify how to make information available technically including how the data is structured and transported.

Contact point

Using this standard

Applies to
  • General Practices MUST follow this standard
  • Other NHS providers, for example: acute trusts, community trusts and pharmacies MAY follow this standard
Impacts on
Implementation of this information standard impacts all health IT systems suppliers providing Yellow Card functionality in systems to the above providers; suppliers should work with their customers to determine necessary changes. Note that as part of the requirements under the NHS GP Systems of Choice Programme (GPSoC), all suppliers of primary care systems must integrate electronic Yellow Card facilities into their clinical software.
Conformance date
01/12/2018
Effective from
01/02/2018

Topics and care settings

Topic
Data definitions and terminologies
Care setting
  • Community health
  • GP / Primary care
  • Hospital
  • Pharmacy
Related standards

Review Information

Scope
NHS Services
Sponsor

John Quinn, Medicines and Healthcare products Regulatory Agency

Senior Responsible Officer

Mick Foy, Medicines and Healthcare products Regulatory Agency

Business Lead
Rebecca Owen, Medicines and Healthcare products Regulatory Agency
Contributor
Medicines and Healthcare products Regulatory Agency
Approval date
12/10/2017
Post Implementation review Date
01/12/2019
Legal authority

Section 250 of the Health and Social Care Act 2012

This information standard is published under section 250 of the Health and Social Care Act 2012

More information

This standard aims to facilitate IT systems to reduce the burden on clinicians.

The Medicines and Healthcare products Regulatory Agency (MHRA) collects reports of suspected adverse drug reactions (ADRs) via the Yellow Card Scheme. These reports provide a source of information on potential drug safety issues allowing the Agency to take regulatory action to protect public health.

Reports can be submitted in a number of ways and this standard is designed to make it easier, and therefore less burdensome, for healthcare professionals to produce and send reports by enabling direct reporting from the clinical system.

Integration of direct Yellow Card reporting into clinical systems makes it easy to complete and send a Yellow Card because much of the information needed can be automatically populated from patient records. At the same time, electronic reporting provides a secure, fast, and convenient method for submitting information about suspected adverse drug reactions.

About this change

This release introduces minor wording changes to enhance user understanding of system requirements and conformance criteria. In addition, clarification is given in respect of XML message and field validations. This should provide more clarity for system suppliers and reduce the risk of transcribing and translational errors by healthcare professionals. The opportunity has also been taken to provide updated details about the mapping of (a) SNOMED CT to MedDRA terms and (b) dm+d to the MHRA drugs dictionary.

Page last updated: 19 June 2024